These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 4619352)

  • 1. Cell-mediated immunity in Cryptococcosis.
    Graybill JR; Alford RH
    Cell Immunol; 1974 Oct; 14(1):12-21. PubMed ID: 4619352
    [No Abstract]   [Full Text] [Related]  

  • 2. T cell response to soluble cryptococcal antigens after recovery from cryptococcal infection.
    Hoy JF; Murphy JW; Miller GG
    J Infect Dis; 1989 Jan; 159(1):116-9. PubMed ID: 2462601
    [No Abstract]   [Full Text] [Related]  

  • 3. Disseminated cryptococcosis in man: decreased lymphocyte transformation in response to Cryptococcus neoformans.
    Diamond RD; Bennett JE
    J Infect Dis; 1973 Jun; 127(6):694-7. PubMed ID: 4575001
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunity in cryptococcosis: an overview.
    Fromtling RA; Shadomy HJ
    Mycopathologia; 1982 Mar; 77(3):183-90. PubMed ID: 7040977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormalities in cell-mediated immunity in patients with Cryptococcus neoformans infection.
    Schimpff SC; Bennett JE
    J Allergy Clin Immunol; 1975 Jun; 55(6):430-41. PubMed ID: 1094054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of cryptococcal antigens on cell-mediated immunity.
    Murphy JW
    Rev Infect Dis; 1988; 10 Suppl 2():S432-5. PubMed ID: 2973118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro human lymphocyte responses to Cryptococcus neoformans. Evidence for primary and secondary responses in normals and infected subjects.
    Miller GP; Puck J
    J Immunol; 1984 Jul; 133(1):166-72. PubMed ID: 6373927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural cell-mediated resistance against Cryptococcus neoformans: a possible role for natural killer (NK) cells.
    Murphy JW
    Curr Top Med Mycol; 1985; 1():135-54. PubMed ID: 3916764
    [No Abstract]   [Full Text] [Related]  

  • 9. Protective cell-mediated immunity against Cryptococcus neoformans.
    Murphy JW
    Res Immunol; 1998; 149(4-5):373-86; discussion 519-22. PubMed ID: 9720955
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunogenic fractions of Cryptococcus neoformans.
    Graybill JR; Straus DC; Nealon TJ; Hague M; Paque RE
    Mycopathologia; 1982 Apr; 78(1):31-9. PubMed ID: 7048099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization of mice with stable, acapsular, yeast-like mutants of Cryptococcus neoformans.
    Fromtling RA; Kaplan AM; Shadomy HJ
    Sabouraudia; 1983 Jun; 21(2):113-9. PubMed ID: 6348975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-mediated effects against Cryptococcus neoformans: evidence for interdependency and collaboration between humoral and cellular immunity.
    Vecchiarelli A; Casadevall A
    Res Immunol; 1998; 149(4-5):321-33; discussion 500-3. PubMed ID: 9720950
    [No Abstract]   [Full Text] [Related]  

  • 13. Pulmonary cryptococcosis: atypical results in the serum test for cryptococcal antigen.
    Jenkins C; Breslin AB
    Aust N Z J Med; 1982 Oct; 12(5):527-30. PubMed ID: 6758749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryptococcal meningitis; significance of positive antigen test on undiluted spinal fluid.
    Salom IL
    N Y State J Med; 1981 Aug; 81(9):1369-70. PubMed ID: 7022273
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunization of mice with an avirulent pseudohyphal form of Cryptococcus neoformans.
    Fromtling RA; Blackstock R; Hall NK; Bulmer GS
    Mycopathologia; 1979 Sep; 68(3):179-81. PubMed ID: 394001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fever of unknown origin and cryptococcal antigen].
    Torroba Alvarez L; Fortún Abete J; Buzón Rueda L; Moreno Caparrós A
    Med Clin (Barc); 1988 Oct; 91(13):514. PubMed ID: 3067009
    [No Abstract]   [Full Text] [Related]  

  • 17. Natural killer cells and Cryptococcus neoformans.
    Murphy JW
    Adv Exp Med Biol; 1993; 335():269-75. PubMed ID: 8237604
    [No Abstract]   [Full Text] [Related]  

  • 18. Dendritic cells in the induction of protective and nonprotective anticryptococcal cell-mediated immune responses.
    Bauman SK; Nichols KL; Murphy JW
    J Immunol; 2000 Jul; 165(1):158-67. PubMed ID: 10861048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfer of immunity to cryptococcosis by T-enriched splenic lymphocytes from Cryptococcus neoformans-sensitized mice.
    Lim TS; Murphy JW
    Infect Immun; 1980 Oct; 30(1):5-11. PubMed ID: 7002791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental cryptococcosis in normal and B-cell-deficient mice.
    Monga DP; Kumar R; Mohapatra LN; Malaviya AN
    Infect Immun; 1979 Oct; 26(1):1-3. PubMed ID: 387600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.